Effect of manipulating serum phosphorus with sevelamer hydrochloride, a phosphate binder, on circulating parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) levels in rats with chronic renal insufficiency

被引：0
|
作者：
Nagano, N
Miyata, S
Abe, M
Kobayashi, N
Wakita, S
Wada, M
机构：
[1] Kirin Brewery Co Ltd, Med Affairs Sect, Tokyo 1508011, Japan
[2] Kirin Brewery Co Ltd, Pharmaceut Dev Labs, Gunma 3701295, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：267P / 267P
页数：1
相关论文
共 50 条
  • [1] Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats
    Nagano, N
    Miyata, S
    Abe, M
    Kobayashi, N
    Wakita, S
    Yamashita, T
    Wada, M
    KIDNEY INTERNATIONAL, 2006, 69 (03) : 531 - 537
  • [2] Fibroblast Growth Factor 23 (FGF23) and its association with parathyroid hormone (PTH), and phosphate ( P) levels in chronic kidney disease (CKD) 1-3
    Sever, F. Lale
    Tasdemir, Mehmet
    Konuk, Dildar
    Canpolat, Nur
    Tas, Cigdem
    Caliskan, Salim
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1501 - 1501
  • [3] Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
    Mansinho, Andre
    Ferreira, Arlindo R.
    Casimiro, Sandra
    Alho, Irina
    Vendrell, Ines
    Costa, Ana Lucia
    Sousa, Rita
    Abreu, Catarina
    Pulido, Catarina
    Macedo, Daniela
    Pacheco, Teresa R.
    Correia, Lurdes
    Costa, Luis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [4] The association between circulating fibroblast growth factor 23 (FGF23) and serum aldosterone level in chronic kidney disease patients
    Khalifa, Amr
    Dohuim, Amira
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2181 - I2183
  • [5] The association between circulating fibroblast growth factor 23 (FGF23) and serum aldosterone level in chronic kidney disease patients
    Khalifa, Amr
    Dohuim, Amira
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [6] Postprandial changes of serum fibroblast growth factor 23(FGF23) levels on high phosphate diet in healthy men.
    Nishida, Y
    Yamanaka-Okumura, H
    Taketani, Y
    Sato, T
    Nashiki, K
    Yamamoto, H
    Takeda, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S344 - S344
  • [7] Effect of Salt Intervention on Serum Levels of Fibroblast Growth Factor 23 (FGF23) in Chinese Adults: An Intervention Study
    Hu, Jia-Wen
    Wang, Yang
    Chu, Chao
    Mu, Jian-Jun
    MEDICAL SCIENCE MONITOR, 2018, 24 : 1948 - 1954
  • [8] Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)
    Adema, Aaltje Y.
    de Jong, Maarten A.
    de Borst, Martin H.
    ter Wee, Pieter M.
    Vervloet, Marc G.
    NEPHRON, 2016, 134 (04) : 215 - 220
  • [9] EFFECT OF PA21, A NEW IRON-BASED PHOSPHATE BINDER ON FIBROBLAST GROWTH FACTOR 23 (FGF23) AND VASCULAR CALCIFICATIONS IN UREMIC RATS
    Phan, O.
    Maillard, M.
    Funk, F.
    Stehle, J. C.
    Bumieri, M.
    JOURNAL OF HYPERTENSION, 2015, 33 : E16 - E17
  • [10] Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans
    Ito, Nobuaki
    Fukumoto, Seiji
    Takeuchi, Yasuhiro
    Takeda, Shu
    Suzuki, Hisanori
    Yamashita, Takeyoshi
    Fujita, Toshiro
    JOURNAL OF BONE AND MINERAL METABOLISM, 2007, 25 (06) : 419 - 422
12345